Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles
- PMID: 33526595
- PMCID: PMC7896333
- DOI: 10.1073/pnas.2020575118
Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles
Abstract
Keratinocyte-derived carcinomas, including squamous cell carcinoma (SCC), comprise the most common malignancies. Surgical excision is the therapeutic standard but is not always clinically feasible, and currently available alternatives are limited to superficial tumors. To address the need for a nonsurgical treatment for nodular skin cancers like SCC, we developed a bioadhesive nanoparticle (BNP) drug delivery system composed of biodegradable polymer, poly(lactic acid)-hyperbranched polyglycerol (PLA-HPG), encapsulating camptothecin (CPT). Nanoparticles (NPs) of PLA-HPG are nonadhesive NPs (NNPs), which are stealthy in their native state, but we have previously shown that conversion of the vicinal diols of HPG to aldehydes conferred NPs the ability to form strong covalent bonds with amine-rich surfaces. Herein, we show that these BNPs have significantly enhanced binding to SCC tumor cell surfaces and matrix proteins, thereby significantly enhancing the therapeutic efficacy of intratumoral drug delivery. Tumor injection of BNP-CPT resulted in tumor retention of CPT at ∼50% at 10 d postinjection, while CPT was undetectable in NNP-CPT or free (intralipid) CPT-injected tumors at that time. BNP-CPT also significantly reduced tumor burden, with a portion (∼20%) of BNP-CPT-treated established tumors showing histologic cure. Larger, more fully established PDV SCC tumors treated with a combination of BNP-CPT and immunostimulating CpG oligodeoxynucleotides exhibited enhanced survival relative to controls, revealing the potential for BNP delivery to be used along with local tumor immunotherapy. Taken together, these results indicate that percutaneous delivery of a chemotherapeutic agent via BNPs, with or without adjuvant immunostimulation, represents a viable, nonsurgical alternative for treating cutaneous malignancy.
Keywords: chemotherapy; drug delivery; immunotherapy; nanoparticle; squamous cell carcinoma.
Conflict of interest statement
Competing interest statement: W.M.S. and M.G. have an ownership interest in and are paid consultants with Stradefy Biosciences, Inc.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7896333/bin/pnas.2020575118fig01.gif)
![Fig. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7896333/bin/pnas.2020575118fig02.gif)
![Fig. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7896333/bin/pnas.2020575118fig03.gif)
![Fig. 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7896333/bin/pnas.2020575118fig04.gif)
![Fig. 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7896333/bin/pnas.2020575118fig05.gif)
Similar articles
-
Camptothecin-loaded mesoporous silica nanoparticles functionalized with CpG oligodeoxynucleotide as a new approach for skin cancer treatment.Int J Pharm. 2024 Jul 20;660:124340. doi: 10.1016/j.ijpharm.2024.124340. Epub 2024 Jun 13. Int J Pharm. 2024. PMID: 38878838
-
The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles.Biomaterials. 2014 Aug;35(24):6595-602. doi: 10.1016/j.biomaterials.2014.04.038. Epub 2014 May 9. Biomaterials. 2014. PMID: 24816286 Free PMC article.
-
Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.Biomaterials. 2017 Nov;144:144-154. doi: 10.1016/j.biomaterials.2017.08.029. Epub 2017 Aug 15. Biomaterials. 2017. PMID: 28829952 Free PMC article.
-
Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.J Adv Res. 2021 Jun 16;36:223-247. doi: 10.1016/j.jare.2021.06.014. eCollection 2022 Feb. J Adv Res. 2021. PMID: 35127174 Free PMC article. Review.
-
Bioadhesive Nanoparticles for Local Drug Delivery.Int J Mol Sci. 2022 Feb 21;23(4):2370. doi: 10.3390/ijms23042370. Int J Mol Sci. 2022. PMID: 35216484 Free PMC article. Review.
Cited by
-
Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.Adv Drug Deliv Rev. 2024 Jun;209:115315. doi: 10.1016/j.addr.2024.115315. Epub 2024 Apr 25. Adv Drug Deliv Rev. 2024. PMID: 38670230 Review.
-
Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021-2023).Front Bioeng Biotechnol. 2023 Nov 1;11:1295323. doi: 10.3389/fbioe.2023.1295323. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38026861 Free PMC article. Review.
-
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.Sci Transl Med. 2023 Nov;15(720):eadi1617. doi: 10.1126/scitranslmed.adi1617. Epub 2023 Nov 1. Sci Transl Med. 2023. PMID: 37910601 Free PMC article.
-
New Methacrylated Biopolymer-Based Hydrogels as Localized Drug Delivery Systems in Skin Cancer Therapy.Gels. 2023 May 1;9(5):371. doi: 10.3390/gels9050371. Gels. 2023. PMID: 37232963 Free PMC article.
-
Nanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment.JID Innov. 2023 Mar 16;3(4):100197. doi: 10.1016/j.xjidi.2023.100197. eCollection 2023 Jul. JID Innov. 2023. PMID: 37205301 Free PMC article. Review.
References
-
- Xiang F., Lucas R., Hales S., Neale R., Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: Empirical relationships. JAMA Dermatol. 150, 1063–1071 (2014). - PubMed
-
- Rogers H. W., Weinstock M. A., Feldman S. R., Coldiron B. M., Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 151, 1081–1086 (2015). - PubMed
-
- Que S. K. T., Zwald F. O., Schmults C. D., Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J. Am. Acad. Dermatol. 78, 237–247 (2018). - PubMed
-
- Hollestein L. M., de Vries E., Nijsten T., Trends of cutaneous squamous cell carcinoma in The Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008. Eur. J. Cancer 48, 2046–2053 (2012). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials